398 related articles for article (PubMed ID: 31718828)
1. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial.
Li Y; Tan J; Wang Q; Duan C; Hu Y; Huang W
Fertil Steril; 2020 Jan; 113(1):197-204. PubMed ID: 31718828
[TBL] [Abstract][Full Text] [Related]
2. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
3. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
[TBL] [Abstract][Full Text] [Related]
5. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
[TBL] [Abstract][Full Text] [Related]
6. [Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].
Ma LK; Jin LN; Yu Q; Xu L
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):294-7. PubMed ID: 17673038
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of metformin or spironolactone enhances efficacy of rosiglitazone in management of PCOS.
Ganie MA; Rashid A; Sood M; Sofi NY; Wani IA; Nisar S; Butt TP; Gupta N; Bhat D; Choh N; Masoodi SR
Gynecol Endocrinol; 2020 Apr; 36(4):308-312. PubMed ID: 31701799
[TBL] [Abstract][Full Text] [Related]
8. Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
Underdal MO; Stridsklev S; Oppen IH; Høgetveit K; Andersen MS; Vanky E
J Clin Endocrinol Metab; 2018 Jun; 103(6):2408-2413. PubMed ID: 29659896
[TBL] [Abstract][Full Text] [Related]
9. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
[TBL] [Abstract][Full Text] [Related]
10. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
Wang QY; Song Y; Huang W; Xiao L; Wang QS; Feng GM
Chin Med J (Engl); 2016 Apr; 129(8):883-90. PubMed ID: 27064030
[TBL] [Abstract][Full Text] [Related]
12. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
[TBL] [Abstract][Full Text] [Related]
13. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
Harborne LR; Sattar N; Norman JE; Fleming R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4593-8. PubMed ID: 15886247
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
18. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
19. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.
Tiwari N; Pasrija S; Jain S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():149-154. PubMed ID: 30690191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
